Advantage Investment Management’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-239
Closed -$4K – 1021
2018
Q1
$4K Hold
239
– – ﹤0.01% 842
2017
Q4
$5K Buy
239
+1
+0.4% +$21 ﹤0.01% 828
2017
Q3
$5K Hold
238
– – ﹤0.01% 819
2017
Q2
$5K Hold
238
– – ﹤0.01% 843
2017
Q1
$6K Hold
238
– – ﹤0.01% 787
2016
Q4
$6K Buy
238
+1
+0.4% +$25 ﹤0.01% 726
2016
Q3
$5K Hold
237
– – ﹤0.01% 740
2016
Q2
$5K Hold
237
– – ﹤0.01% 710
2016
Q1
$4K Buy
237
+1
+0.4% +$15 ﹤0.01% 714
2015
Q4
$4K Buy
236
+2
+0.9% +$31 ﹤0.01% 721
2015
Q3
$3K Buy
234
+2
+0.9% +$32 ﹤0.01% 723
2015
Q2
$4K Buy
232
+1
+0.4% +$21 ﹤0.01% 722
2015
Q1
$4K Buy
+231
New +$3.96K ﹤0.01% 716

Other funds holding PTEN

Advantage Investment Management's PTEN Position: Q2 2018 in Review

Advantage Investment Management sold out of Patterson-UTI (PTEN) in Q2 2018, closing a stake of 239 shares — an estimated $4K sold.

Advantage Investment Management first reported a position in PTEN in Q1 2015 and held it in 13 quarters. The position peaked at $6K in Q1 2017. 328 funds tracked by Wall St. Rank hold PTEN as of Q2 2018.

  • Advantage Investment Management reported no remaining Patterson-UTI position as of Q2 2018 after selling out during the quarter.
  • Advantage Investment Management sold 239 Patterson-UTI shares in Q2 2018, an estimated $4K.
  • Advantage Investment Management first reported a position in Patterson-UTI in Q1 2015 and held it in 13 quarters.
  • Advantage Investment Management's Patterson-UTI position peaked at $6K in Q1 2017.
  • 328 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2018.

Based on Advantage Investment Management's 13F filing for Q2 2018, filed 13 Aug 2018.